English | 简体中文 | 繁體中文 | 한국어
Share:
Ashland declares force majeure in Europe on 1.4 butanediol, tetrahydrofuran and formaldehyde after fire shuts down production at manufacturing facility in Marl, Germany

COVINGTON, Kentucky, August 11, 2017 - Ashland (NYSE: ASH) today announced it has declared a force majeure in Europe on 1.4 butanediol (BDO), tetrahydrofuran (THF) and formaldehyde as a result of a fire at its manufacturing facility in Marl, Germany, that led to the shutdown of production operations on August 10.

Production has been suspended while an investigation into the cause and extent of the fire takes place. As a result, the Marl facility is currently unable to produce any 1.4 BDO, THF or formaldehyde, and the availability of product is significantly reduced.

Ashland is working with affected customers to minimize the impact to their respective businesses, and will continue to provide updates regarding supply capability.

About Ashland

Ashland Global Holdings Inc. (NYSE: ASH) is a premier global specialty chemicals company serving customers in a wide range of consumer and industrial markets, including adhesives, architectural coatings, automotive, construction, energy, food and beverage, personal care and pharmaceutical. At Ashland, we are nearly 7,000 passionate, tenacious solvers - from renowned scientists and research chemists to talented engineers and plant operators - who thrive on developing practical, innovative and elegant solutions to complex problems for customers in more than 100 countries. Visit ashland.com to learn more.

C-ASH

FOR FURTHER INFORMATION:

Investor Relations:

Seth A. Mrozek

+1 (859) 815-3527

samrozek@ashland.com

Media Relations:

Gary Rhodes

+1 (859) 815-3047

glrhodes@ashland.com





This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ashland Inc. via Globenewswire

Copyright © Thomson Reuters 2018. All rights reserved.
Press Releases
Basilea reports clinical phase 3 study start with antibiotic ceftobiprole in skin infections under BARDA contract  
Feb 23, 2018 07:15 ET
Heijmans annual results 2017: sound basis for continued recovery  
Feb 23, 2018 07:12 ET
SeaBird Exploration: Fourth quarter 2017 report  
Feb 23, 2018 07:00 ET
SIKA ACHIEVES RECORD RESULTS IN 2017  
Feb 23, 2018 05:00 ET
Galapagos delivered in 2017  
Feb 22, 2018 22:01 ET
JCPenney Launches Obsess, a Totally Fun, Totally Stylish Tween Brand  
Feb 22, 2018 01:33 ET
Lubrizol Expands Global Capabilities and TPU Capacity  
Feb 20, 2018 20:03 ET
INGREDION'S UNIQUE VALUE PROPOSITION - A WINNING RECIPE; EXECUTIVES WILL PRESENT AT CAGNY 2018 CONFERENCE  
Feb 20, 2018 19:03 ET
Enterprise CPaaS spend set to quadruple to $6.7bn by 2022, estimates Juniper Research  
Feb 20, 2018 18:03 ET
CLX Communications & DeviceRadio Partner to Simplify Production & Launch of IoT devices  
Feb 20, 2018 03:03 ET
More News >>
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: